Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Neu

Showing results (171-180 of 1,127) with videos related to

Pageof 113
Sort By:
Bulletin of the New York Academy of Medicine|March 25, 2009
Concluding remarksH C Neu
Diagnostic Microbiology and Infectious Disease|December 1, 1983
Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compoundsH C Neu
The American Journal of Medicine|February 8, 1985
Current state of infectious diseases--potential areas of directed therapy with aztreonamH C Neu
Antimicrobial Agents and Chemotherapy|September 1, 1983
In vitro activity of midecamycin, a new macrolide antibioticH C Neu
Annals of Internal Medicine|November 1, 1978
What should the clinician expect from the microbiology laboratory?H C Neu
Annals of Internal Medicine|November 1, 1978
How is the medical student being trained in microbiology and infections?H C Neu
The Journal of Infectious Diseases|May 1, 1978
Comparison of the pharmacokinetics of cefamandole and other cephalosporin compoundsH C Neu
The Journal of Antimicrobial Chemotherapy|April 1, 1988
Issues in gram-positive infections: the present and the futureH C Neu
The American Journal of Medicine|November 29, 1985
Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamasesH C Neu
The American Journal of Medicine|June 28, 1985
Emerging perspectives in management and prevention of infectious diseases. A summaryH C Neu
Pageof 113

Showing results (171-180 of 1,127) with videos related to

Sort By:
Pageof 113
Bulletin of the New York Academy of Medicine|March 25, 2009
Concluding remarksH C Neu
Diagnostic Microbiology and Infectious Disease|December 1, 1983
Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compoundsH C Neu
The American Journal of Medicine|February 8, 1985
Current state of infectious diseases--potential areas of directed therapy with aztreonamH C Neu
Antimicrobial Agents and Chemotherapy|September 1, 1983
In vitro activity of midecamycin, a new macrolide antibioticH C Neu
Annals of Internal Medicine|November 1, 1978
What should the clinician expect from the microbiology laboratory?H C Neu
Annals of Internal Medicine|November 1, 1978
How is the medical student being trained in microbiology and infections?H C Neu
The Journal of Infectious Diseases|May 1, 1978
Comparison of the pharmacokinetics of cefamandole and other cephalosporin compoundsH C Neu
The Journal of Antimicrobial Chemotherapy|April 1, 1988
Issues in gram-positive infections: the present and the futureH C Neu
The American Journal of Medicine|November 29, 1985
Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamasesH C Neu
The American Journal of Medicine|June 28, 1985
Emerging perspectives in management and prevention of infectious diseases. A summaryH C Neu
Pageof 113